Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorKarabacak, Elif
dc.contributor.authorEken, Hazal
dc.contributor.authorDallali, Ilhem
dc.contributor.authorArslan, Rana
dc.date.accessioned2025-12-28T16:40:11Z
dc.date.available2025-12-28T16:40:11Z
dc.date.issued2024
dc.identifier.issn0022-3573
dc.identifier.issn2042-7158
dc.identifier.urihttps://doi.org/10.1093/jpp/rgae034
dc.identifier.urihttps://hdl.handle.net/20.500.12933/2446
dc.description.abstractWe purposed to explore the consequences of the use quercetin and fisetin alone and in combination with pregabalin and gabapentin, which are used in the management of neuropathic pain, and on neuropathic pain in general. The anti-allodynic effect of various doses (5, 10, and 20 mg/kg) of quercetin and fisetin, both singly and in combination with pregabalin and gabapentin, was evaluated by developing a neuropathic pain model induced by chronic constrictive nerve damage in rats. The effectiveness of these flavonoids was investigated by combining them with gabapentin (50 mg/kg) and pregabalin (15 mg/kg), choosing the effectual dose of 10 mg/kg and the dose of 5 mg/kg, which did not show significant antiallodynic effects. In groups combined with gabapentin and pregabalin, it was determined that they showed a significant antiallodynic effect compared with 50 mg/kg gabapentin and 15 mg/kg pregabalin. In conclusion, in our combination studies, it was observed that the effectiveness of gabapentin and pregabalin, was increased and the duration of effect was prolonged when used with lower doses of flavonoids. Based on these findings; it is possible to say that quercetin and fisetin are potential agents that can be used alone or in combination with other effective treatments to alleviate neuropathic pain.
dc.description.sponsorshipAnadolu University Research Foundation [AUBAP- 2004S017]
dc.description.sponsorshipThis article is based on the PhD thesis of Elif Karabacak and supported financially by the Anadolu University Research Foundation (AUBAP- 2004S017, Eskisehir, Turkey).
dc.language.isoen
dc.publisherOxford Univ Press
dc.relation.ispartofJournal of Pharmacy And Pharmacology
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectfisetin
dc.subjectquercetin
dc.subjectneuropathic pain
dc.subjectgabapentin
dc.subjectpregabalin
dc.titleUse of kersetin and fisetin flavonoids in combination with pregabalin and gabapentin in the treatment of neuropathic pain
dc.typeArticle
dc.identifier.orcid0000-0003-2360-511X
dc.identifier.orcid0000-0001-9876-9106
dc.departmentAfyonkarahisar Sağlık Bilimleri Üniversitesi
dc.identifier.doi10.1093/jpp/rgae034
dc.identifier.volume76
dc.identifier.issue7
dc.identifier.startpage824
dc.identifier.endpage833
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.department-temp[Karabacak, Elif; Dallali, Ilhem] Anadolu Univ, Grad Sch Educ, Dept Pharmacol, Eskisehir, Turkiye; [Eken, Hazal] Afyonkarahisar Hlth Sci Univ, Fac Pharm, Dept Pharmacol, Afyon, Turkiye; [Arslan, Rana] Anadolu Univ, Fac Pharm, Dept Pharmacol, Eskisehir, Turkiye; [Karabacak, Elif] Adana City Training & Res Hosp Pharm, 4522 St,1 Yuregir, Adana, Turkiye
dc.identifier.pmid38588462
dc.identifier.wosWOS:001198278900001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.snmzKA_WoS_20251227


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster